FDA Approved: OCREVUS — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA approved Ocrevus (ocrelizumab) in an original application from Genentech for the treatment of multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ocrevus (ocrelizumab)

Snippet

ORIG AP for OCREVUS (OCRELIZUMAB)